Providence Capital Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Providence Capital Advisors, LLC

  • $445 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$71.48 - $86.85 $1,000 - $1,215
-14 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$74.28 - $92.69 $1,039 - $1,297
14 New
14 $1,000
Q2 2019

Aug 13, 2019
SELL
$80.35 - $93.9 $883 - $1,032
-11 Closed
0 $0
Q1 2019

May 08, 2019
BUY
$84.2 - $98.62 $926 - $1,084
11 New
11 $1,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Providence Capital Advisors, LLC Portfolio

Follow Providence Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email